title: The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: results of a multicentre randomized controlled trial.
authors.affiliation: Department of Dermatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands. c.prinsen@vumc.nl.|Department of Epidemiology and Biostatistics, EMGO+ Institute for Health and Care Research, VU University Medical Center, De Boelelaan 1089a, 1081 HV, Amsterdam, the Netherlands. c.prinsen@vumc.nl.
authors.forename: C A C
authors.initials: CA
authors.lastname: Prinsen
authors.affiliation: Department of Dermatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
authors.forename: P I
authors.initials: PI
authors.lastname: Spuls
authors.affiliation: Division of Clinical Methods and Public Health, Master Evidence Based Practice, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
authors.forename: R
authors.initials: R
authors.lastname: Lindeboom
authors.affiliation: Department of Medical Psychology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
authors.forename: M A G
authors.initials: MA
authors.lastname: Sprangers
authors.affiliation: Department of Dermatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.|Department of Dermatology, VU University Medical Center, De Boelelaan 1117, P.O. Box 7057, 1007 MB, Amsterdam, the Netherlands.
authors.forename: M A
authors.initials: MA
authors.lastname: de Rie
authors.affiliation: Department of Dermatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: de Korte
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001688:Biological Products / Q000627:therapeutic use*; D016000:Cluster Analysis; D003131:Combined Modality Therapy; D003879:Dermatologic Agents / Q000627:therapeutic use*; D000068800:Etanercept / Q000627:therapeutic use*; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011565:Psoriasis / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D001688:Biological Products; D003879:Dermatologic Agents; D000068800:Etanercept